Impact of Valve Surgery on 6-Month Mortality in Adults with Complicated, Left-Sided Native Valve Endocarditis: A Propensity Analysis

JAMA

Volumn 290, Issue 24, 2003, Pages 3207-3214

  Vikram, Holenarasipur R ^a,b   Buenconsejo, Joan ^a,c   Hasbun, Rodrigo ^a,d   Quagliarello, Vincent J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

^c YALE UNIVERSITY   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0346245899     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.24.3207     Document Type: Article

References (44)

1. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53-60.
2. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289:1933-1940.
3. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.
4. Wallace AG, Young WGJ, Osterhout S. Treatment of acute bacterial endocarditis by valve excision and replacement. Circulation. 1965;31:450-453.
5. Braniff BA, Shumway NE, Harrison DC. Valve replacement in active bacterial endocarditis. N Engl J Med. 1967;276:1464-1467.
6. Dinubile MJ. Surgery in active endocarditis. Ann Intern Med. 1982;96:650-659.
7. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998;98:2936-2948.
8. Olaison L, Pettersson G. Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 2002;16:453-475, xi.
9. Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict clinical complications: a meta-analysis. J Am Soc Echocardiogr. 1997;10:562-568.
10. Mathew J, Anand A, Addai T, Freels S. Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis. Angiology. 2001;52:801-809.
11. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med. 1994;96:200-209.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
13. Lash TL, Silliman RA. A comparison of the National Death Index and Social Security Administration databases to ascertain vital status. Epidemiology. 2001;12:259-261.
14. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
15. Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983;73:1270-1274.
16. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
17. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327-333.
18. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
19. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
20. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA. 2001;286:1187-1194.
21. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-1069.
22. Middlemost S, Wisenbaugh T, Meyerowitz C, et al. A case for early surgery in native left-sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667.
23. Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation. 1978;58:589-597.
24. Young JB, Welton DE, Raizner AE, et al. Surgery in active infective endocarditis. Circulation. 1979;60(2 pt 2):77-81.
25. Karth G, Koreny M, Binder T, et al. Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care. 2002;6:149-154.
26. Knosalla C, Weng Y, Yankah AC, et al. Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess-11 year results. Eur Heart J. 2000;21:490-497.
27. Choussat R, Thomas D, Isnard R, et al. Perivalvular abscesses associated with endocarditis: clinical features and prognostic factors of overall survival in a series of 233 cases. Eur Heart J. 1999;20:232-241.
28. Karalis DG, Blumberg EA, Vilaro JF, et al. Prognostic significance of valvular regurgitation in patients with infective endocarditis. Am J Med. 1991;90:193-197.
29. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000;160:2781-2787.
30. Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J. 2001;142:75-80.
31. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62.
32. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892
33. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-1886.
34. Croft CH, Woodward W, Elliott A, Commerford PJ, Barnard CN, Beck W. Analysis of surgical versus medical therapy in active complicated native valve infective endocarditis. Am J Cardiol. 1983;51:1650-1655.
35. Pompilio G, Brockmann C, Bruneau M, et al. Long-term survival after aortic valve replacement for native active infective endocarditis. Cardiovasc Surg. 1998;6:126-132.
36. Mullany CJ, Chua YL, Schaff HV, et al. Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc. 1995;70:517-525.
37. d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of surgery for active infective endocarditis. Eur J Cardiothorac Surg. 1997;11:46-52.
38. Cotrufo M, Carozza A, Romano G, De Feo M, Della Corte A. Infective endocarditis of native cardiac valves: 22 years' surgical experience. J Heart Valve Dis. 2001;10:478-485.
39. Langley SM, Alexiou C, Stafford HM, et al. Aortic valve replacement for endocarditis: determinants of early and late outcome. J Heart Valve Dis. 2000;9:697-704.
40. Schulz R, Werner GS, Fuchs JB, et al. Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990's. Eur Heart J. 1996;17:281-288.
41. Thalme A, Nygren AT, Julander I, Freyschuss U. Endocarditis: clinical outcome and benefit of transoesophageal echocardiography. Scand J Infect Dis. 2000;32:303-307.
42. Foody JM, Cole CR, Blackstone EH, Lauer MS. A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am J Cardiol. 2001;87:706-711.
43. Lytle BW, Blackstone EH, Loop FD, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg. 1999;117:855-872.
44. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.